The IQ-UIP AI software may bolster computed tomography diagnosis of usual interstitial pneumonia (UIP), which is reportedly misdiagnosed in over 50 percent of cases.
The Food and Drug Administration (FDA) has granted 510(k) clearance for IQ-UIP, an artificial intelligence (AI)-powered software for enhancing computed tomography (CT) diagnosis of usual interstitial pneumonia (UIP).
Leveraging deep learning technology, IQ-UIP provides automated analysis of conventional CT scans with rapid detection of UIP patterns such as honeycombing and subpleural fibrosis, according to 4DMedical, the developer of IQ-UIP.
Emphasizing that more than 50 percent of UIP is initially misdiagnosed, 4DMedical noted the condition’s non-specific symptomatology may mimic other conditions such as asthma and chronic obstructive pulmonary disease (COPD).
In addition to a rapid diagnosis of UIP, which is characterized by chronic inflammation and progressive lung fibrosis, 4DMedical said IQ-UIP provides automated referral workflows for specialists, facilitating timely care for a condition that has a median survival of one to two years after diagnosis.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.